Uganda: 60 Percent of Cancers Are Infection-Related, Uci Officials Warn
[Monitor] Doctors at Uganda Cancer Institute on Tuesday revealed that 60 percent of cancers are attributable to infectious pathogens. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 17, 2019 Category: African Health Source Type: news

Simple blood test can spot if breast cancer will return up to TWO YEARS earlier than current scans
A study by the University of Leicester and Imperial College London looked for mutant DNA released from dying tumours in the blood of 49 breast-cancer patients over several years (stock) (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2019 Category: Consumer Health News Source Type: news

Cancer symptoms: The common digestive issue which could actually be a sign of cancer
CANCER SYMPTOMS can often be confused with much less serious issues, so it ’s important to be aware of anything which could potentially signal the disease. This common digestive issue, for example, could easily be shrugged off when it could be a sign of cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 17, 2019 Category: Consumer Health News Source Type: news

AI can spot malpositioned catheters on pediatric x-rays
An artificial intelligence (AI) algorithm can automatically analyze pediatric...Read more on AuntMinnie.comRelated Reading: 5 ways artificial intelligence can augment clinicians AI improves contouring accuracy for radiation oncology Practical considerations of AI: Part 2 -- ROI variables Are AI algorithms vulnerable to manipulation by users? SIR: Virtual reality beats fluoroscopy for catheter placement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2019 Category: Radiology Source Type: news

Ga-68 PSMA-PET/CT for prostate wins Australian favor
When a prostate cancer staging exam is needed, clinicians at one Australian...Read more on AuntMinnie.comRelated Reading: Ga-68 PSMA-11 PET/MRI improves prostate cancer detection Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients Ga-68 PSMA-11 PET/MRI advances prostate cancer detection Gallium-labeled PET tracer could advance cancer detection SNMMI: Early prostate cancer therapy extends lives (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 17, 2019 Category: Radiology Source Type: news

Even moderate intake of red meat raises cancer risk,  study finds
People more or less keeping to NHS guidelines at higher risk than those who eat littleEating even the moderate amounts of red and processed meat sanctioned by government guidelines increases the likelihood of developing bowel cancer, according to the largest UK study of the risks ever conducted.The Department of Health and Social Care (DHSC) suggests anyone who eats more than 90g of red or processed meat per day should try to cut down to 70g or less, because of the known link with bowel cancer. TheNHS describes 90g of red meat as “equivalent to around three thinly cut slices of beef, lamb or pork, where each slice is...
Source: Guardian Unlimited Science - April 17, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Bowel cancer Medical research Meat UK news Health Science Society Food Source Type: news

Implementing a Toxicity Screening Form to Report Chemo Side Effects
The number of patients reporting side effects related to chemotherapy increased by more than 40 percentage points after the implementation of a chemotherapy toxicity screening form. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Niraparib Offers New Option in Heavily Pretreated Ovarian Cancer
Researchers conducted the QUADRA trial to examine if niraparib could improve outcomes in heavily pretreated patients with ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Diet high in leucine may fuel breast cancer's drug resistance
(Beth Israel Deaconess Medical Center) A team led by Senthil Muthuswamy, PhD, at the Cancer Center at Beth Israel Deaconess Medical Center, has discovered an unexpected relationship between levels of the amino acid leucine (found in beef, chicken, pork and fish and other foods) and the development of tamoxifen resistance in ER+ breast cancer. These findings reveal a potential new strategy for overcoming resistance to endocrine drugs in ER+ breast cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

New study targets Achilles' heel of pancreatic cancer, with promising results
(Salk Institute) Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread throughout the body. Now, Salk Institute researchers, along with an international team of collaborators, have uncovered the role of a signaling protein, called LIF, that may be the Achilles' heel of pancreatic cancer. The findings show that pancreatic stellate cells -- resident cells typically dormant in normal tissue -- secrete LIF to convey stimulatory signals to tumor cells to drive pancreatic cancer development and progression. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Researchers pinpoint tumor-related protein, slow progression of cancers
(University of Nebraska-Lincoln) A new study in Nature has identified a potential strategy for treating multiple forms of cancerous tumors: targeting a protein that maliciously rewires immune cells and impedes cancer therapies. The researchers showed that inhibiting the protein with an existing compound helped slow or even reject tumors stemming from four cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

New automated biological-sample analysis systems to accelerate disease detection
(Polytechnique Montr é al) Professor Thomas Gervais of Polytechnique Montr é al and his students Pierre-Alexandre Goyette and É tienne Boulais, in partnership with the team led by Professor David Juncker of McGill University, have developed a new microfluidic process aimed at automating protein detection by antibodies. This work, the topic of an article in Nature Communications, points to the arrival of new portable instruments to accelerate the screening process and molecule analysis in biological laboratories to accelerate research in cancer biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Preventing triple negative breast cancer from spreading
(University of Missouri-Columbia) A protein called p53 suppresses and kills cancer in people. However, a defective, mutant form of p53 helps cancer cells grow and multiply. Researchers at the University of Missouri have now found that a combination drug therapy reduces the spread of triple negative breast cancer to other locations of the body by 50 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Bacterial therapy in a dish
(Columbia University School of Engineering and Applied Science) Biomedical engineers have developed a system that can study 10s to 100s of programmed bacteria within mini-tissues in a dish, condensing study time from months to days. The speed and high throughput of their technology allows for stable growth of bacteria within tumor spheroids and can also be used for other bacteria species and cell types. The team says this study is the first to rapidly screen and characterize bacteria therapies in vitro. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

Triple negative breast cancers can adopt reversible state that is resistant to chemotherapy
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent adaptations, but rather transiently turning on molecular pathways that protect the cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2019 Category: Biology Source Type: news

Fragments of cellular machinery reveal unexpected variability among cancers
(Thomas Jefferson University) New research shows the mitochondrial genome may play a significant role in these fragment interactions with cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2019 Category: Biology Source Type: news

Cervical cancer subtype rising in some sub-populations
(American Cancer Society) A new study reports that a type of cervical cancer that is less amenable to Pap testing is increasing in several subpopulations of women, pointing to the growing importance of human papillomavirus (HPV) testing and vaccination (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

IDIBELL -- ICO researchers set new bases to develop therapies against colorectal cancer
(IDIBELL-Bellvitge Biomedical Research Institute) IDIBELL -- ICO researchers in Barcelona have found that inactivation of two proteins make tumoral cells more sensitive to chemotherapy. This sets new bases to develop therapies against colorectal cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Scientists enter research collaboration to outsmart cancer
(InSilico Medicine, Inc.) Today, Insilico Medicine, a biotech company developing the end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, announces its partnership with Arctoris, the world's first fully automated cancer research laboratory providing robotic experimentation in the cloud, Science Entrepreneur Club, a life sciences network and Cluster Market, a leading online equipment sharing and booking platform enabling and accelerating science. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

NRG Oncology awarded NCI funding for next 6 years, receives 'exceptional' score
(NRG Oncology) NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of over $95 million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

NRG Oncology SDMC awarded NCI funding for next 6 years with 'outstanding' score
(NRG Oncology) The NRG Oncology Statistics and Data Management Center (SDMC) was notified that the center will be awarded six more years of funding from the National Cancer Institute (NCI) and will continue to serve the NCI National Clinical Trials Network (NCTN) group NRG Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects
(Institute for Quality and Efficiency in Health Care) Study indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system. Overall, added benefit not proven. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Cervical cancer is more aggressive when human papillomavirus is not detected
(Barcelona Institute for Global Health (ISGlobal)) Cervical cancer negative for the human papillomavirus (HPV) is rare but more aggressive: it is more frequently diagnosed at advanced stages, with more metastasis and reduced survival. These are the conclusions of a study co-led by ISGlobal, an institution supported by 'la Caixa,' the Hospital Clinic and the University of Barcelona. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Study reveals factors behind embryonic stem cell state
(Monash University) An international collaboration has found for the first time that two new epigenetic regulators, TAF5L and TAF6L, maintain self-renewal of embryonic stem cells. The scientists also found that these proteins activate c-Myc (a well-known cancer gene), and its regulatory network. This is the first time scientists have been able to show what these regulators do and how they control gene expression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Key protein a possible new target in the treatment of pancreatic cancer
(Stand Up To Cancer) Pancreatic Cancer Collective-funded research (Lustgarten Foundation and Stand Up To Cancer) from Dr. Tony Hunter (Salk Institute) and the SU2C-CRUK-Lustgarten Pancreatic Cancer Dream Team has found the presence of a key protein (Leukemia Inhibitory Factor or LIF) in PDAC microenvironment may be an exploitable treatment target to slow tumor progression or metastasis and may lead to the development of new targeted strategies for pancreatic cancer therapy. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 17, 2019 Category: International Medicine & Public Health Source Type: news

Partner status influences sexual problems and self-efficacy in survivors of breast cancer
(The North American Menopause Society (NAMS)) Vaginal dryness and painful intercourse are some of the more common adverse events of post-breast cancer treatment therapies and often lead to sexual dissatisfaction and an overall lower quality of life (QOL). However, a new study finds that partnered women may fare better than those without a partner. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

The Leukemia Atlas: researchers unveil proteins that signal disease
(University of Texas at San Antonio) Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after the initial diagnosis. To improve that survival rate, researchers at The University of Texas at San Antonio (UTSA) and the University of Texas MD Anderson Cancer Center created an online atlas to identify and classify protein signatures present at AML diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2019 Category: Cancer & Oncology Source Type: news

UW's Institute of Protein Design receives $45M from the Audacious Project
The institute will use funds to not only attempt to design a universal flue vaccine that is capable of providing lifetime immunization, but also advanced protein containers for targeted gene delivery and smart proteins capable of identifying cancerous or unhealthy cells. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 17, 2019 Category: Health Management Authors: Coral Garnick Source Type: news

Artificial intelligence performs as well as experienced radiologists in detecting prostate cancer
FINDINGSUCLA researchers have developed a new artificial intelligence system to help radiologists improve their ability to diagnose prostate cancer. The system, called FocalNet, helps identify and predict the aggressiveness of the disease evaluating magnetic resonance imaging, or MRI, scans, and it does so with nearly the same level of accuracy as experienced radiologists. In tests, FocalNet was 80.5 percent accurate in reading MRIs, while radiologists with at least 10 years of experience were 83.9 percent accurate.BACKGROUNDRadiologists use MRI to detect and assess the aggressiveness of malignant prostate tumors. However,...
Source: UCLA Newsroom: Health Sciences - April 17, 2019 Category: Universities & Medical Training Source Type: news

UW's Institute of Protein Design receives $45M from the Audacious Project
The institute will use funds to not only attempt to design a universal flue vaccine that is capable of providing lifetime immunization, but also advanced protein containers for targeted gene delivery and smart proteins capable of identifying cancerous or unhealthy cells. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 17, 2019 Category: Biotechnology Authors: Coral Garnick Source Type: news

Cancer symptoms: Three surprising signs you might not associate with the disease
CANCER symptoms are not always easy to detect. Most people are aware of some signs of the disease, such as a lump, but there are many other, much more subtle symptoms which you may be surprised are linked to cancer. Here are three symptoms of the disease you should always get checked out. (Source: Daily Express - Health)
Source: Daily Express - Health - April 17, 2019 Category: Consumer Health News Source Type: news

Eating 76g of red and processed meat STILL raises your risk of bowel cancer
Scientists at the University of Oxford compared the risk between people who stick to NHS guidelines on red and processed meat consumption - 70g a day - and those who don't. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2019 Category: Consumer Health News Source Type: news

A rasher of bacon a day 'ups cancer risk'
Eating even small amounts of red or processed meat increases the risk of bowel cancer, study finds. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 17, 2019 Category: Consumer Health News Source Type: news

A rasher of bacon 'ups cancer risk'
Eating even small amounts of red or processed meat increases the risk of bowel cancer, study finds. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 17, 2019 Category: Consumer Health News Source Type: news

Top 10 Things to Consider When Designing Platform, Basket and Umbrella...
Oncology trials are becoming increasingly complex owing to the evolution of study designs (platform, basket and umbrella trials). eClinical technology has the capacity to accommodate the complexities...(PRWeb April 17, 2019)Read the full story at https://www.prweb.com/releases/top_10_things_to_consider_when_designing_platform_basket_and_umbrella_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb16249297.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2019 Category: Pharmaceuticals Source Type: news

Oncology Clinical Trials – The Paradigm Shift of Basket Trials: Key...
In basket trials, cancers with differing histologies are pooled and the common element is a singular genetic mutation or protein alteration. The trial tests a drug that targets a common biologic...(PRWeb April 17, 2019)Read the full story at https://www.prweb.com/releases/oncology_clinical_trials_the_paradigm_shift_of_basket_trials_key_considerations_upcoming_webinar_hosted_by_xtalks/prweb16249240.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 17, 2019 Category: Pharmaceuticals Source Type: news

After a cancer diagnosis at 30 'shook her world' this P.E.I. woman wants to spread hope
P.E.I. native Michelle Fuller was first diagnosed with cancer in 1999 at the age of 30, when she had surgery to remove her right eye, her cheekbone and part of the roof of her mouth. She's telling her story in a new book, A Fuller Life written by Sue Anne Linde. (Source: CBC | Health)
Source: CBC | Health - April 17, 2019 Category: Consumer Health News Tags: News/Canada/PEI Source Type: news

Two US cancer patients treated with controversial CRISPR technology
Scientists at the University of Pennsylvania have edited the genes of two adult patients with sarcoma and myeloma using the controversial CRISPR technology, a spokesperson told NPR. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2019 Category: Consumer Health News Source Type: news

Eating no more than recommended levels of red meat still raises risk of bowel cancer
Risk is raised in people eating just 76g of red and processed meat a day, which is roughly in line with government recommendations Related items fromOnMedica Lower cancer risk in people with higher vitamin D levels Cancer rates could rise due to growing intake of highly processed food Scientists equate wine to cigarette consumption to flag up cancer risk Obesity as cause of cancer set to overtake smoking Millennials top obesity chart before reaching middle age (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 17, 2019 Category: UK Health Source Type: news

Comic-style information can better prepare surgical patients
Patients who received comic-style information better understood what the procedure entailed and were less anxious Related items fromOnMedica Sentinel node biopsy first to check spread of oral cancer GPs should be told when patients have cosmetic surgery Gastric banding has strong impact on cardio risks No safety evidence to back 8% of hip implants Placebo may not rely on deception (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 17, 2019 Category: UK Health Source Type: news

The Kidney Cancer Association Announces $1.3 Million in New Research Opportunities
HOUSTON–April 16, 2019– The Kidney Cancer Association (KCA) is pleased to announce its Board of Directors recently approved $1.3 million in new grant funding to advance early detection and new treatments for kidney cancer. The application process opens on April 17 and closes on May 20. Award winners will be announced in the Fall of 2019.“The KCA Board of Directors is committed to providing research funding with the goal of identifying new treatments and finding new ways to prevent and manage the disease,” said Christopher Wood, Board President.“With these advancements in research and a greater...
Source: Kidney Cancer Association - April 16, 2019 Category: Urology & Nephrology Source Type: news

EC Approves Olaparib for BRCA Breast Cancer EC Approves Olaparib for BRCA Breast Cancer
The European Commission has cleared olaparib (Lynparza, AstraZeneca/MSD) for the treatment of locally advanced or metastatic BRCA1/2 breast cancer.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 16, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Local teen ’s motivation to serve creates STEM program for high school students at Karmanos Cancer Institute
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - April 16, 2019 Category: Cancer & Oncology Source Type: news

Don ’ t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown. (Source: NYT Health)
Source: NYT Health - April 16, 2019 Category: Consumer Health News Authors: HEATHER MURPHY Tags: Genetics and Heredity Tests (Medical) Breast Cancer DNA (Deoxyribonucleic Acid) Ovarian Cancer 23andMe Promethease (SNPedia) Invitae Corp. Source Type: news

FDA To Boston Scientific: Stop Selling Pelvic Mesh Tied To Injuries In Women
WASHINGTON (AP) — U.S. health regulators on Tuesday halted sales of a type of surgical mesh used to repair pelvic conditions in women, following years of patients’ reports of injuries and complications from the implants. The Food and Drug Administration ordered the two remaining makers of the mesh — Boston Scientific and Coloplast — to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. Several other major manufacturers, including Johnson & Johnson, previously stopped making the mesh. The FDA action does not apply to surgical mesh used to treat ot...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 16, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Boston Scientific FDA Source Type: news

Deborah Norville "so grateful" after cancer surgery
The "Inside Edition" anchor admitted she had been "very fearful" because her doctor was forthcoming about the risks (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - April 16, 2019 Category: Consumer Health News Source Type: news

Director of the UAB cancer center steps down
Dr. Michael Birrer has resigned from his post as director of the O'Neal Comprehensive Cancer Center at UAB after serving in the role since August 2017. Dr. Ravi Bhatia, director of the UAB Division of Hematology-Oncology and deputy director of the O’Neal Cancer Center, has been named interim director of the center, effective immediately.  “Bhatia, a globally known researcher and practicing clinician, will carry forward the center’s missio n as it works every day to provide the highest quality… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 16, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Director of the UAB cancer center steps down
Dr. Michael Birrer has resigned from his post as director of the O'Neal Comprehensive Cancer Center at UAB after serving in the role since August 2017. Dr. Ravi Bhatia, director of the UAB Division of Hematology-Oncology and deputy director of the O’Neal Cancer Center, has been named interim director of the center, effective immediately.  “Bhatia, a globally known researcher and practicing clinician, will carry forward the center’s missio n as it works every day to provide the highest quality… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 16, 2019 Category: American Health Authors: Tyler Patchen Source Type: news

Tool Calculates Competing Risks of Death in Older Women With Early Breast Cancer Tool Calculates Competing Risks of Death in Older Women With Early Breast Cancer
A risk calculator incorporating age, comorbidities and estrogen receptor status can estimate competing risks of death for older women with stage 1 breast cancer, potentially aiding therapeutic decision making, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 16, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Race and PSA Impact Mortality in Low-Risk Prostate Cancer Race and PSA Impact Mortality in Low-Risk Prostate Cancer
Dr Gerald Chodak discusses recent findings suggesting that race does not affect mortality risk when PSA levels are below 4 ng/mL.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 16, 2019 Category: Consumer Health News Tags: Urology Commentary Source Type: news